News | Clue Drives Innovation in Women's Health as CEO Rhiannon White Shares Her Vision
Clue's new CEO, Rhiannon White, recently spoke with NewsMedical about her career and Clue's innovative mission in women's health. A leading global menstrual health app, Clue currently serves more than 10 million users across over 190 countries. White explained that Clue uses data to address gaps in women's health research, particularly in under-researched conditions such as polycystic ovary syndrome (PCOS).
Clue's Mission and White's Personal Experience
White joined Clue as Chief Product Officer in 2022 and was recently promoted to CEO. In the interview, she described her strong commitment to Clue's mission and why she joined the company. She was especially drawn to the importance of data in women's health research and its role in helping women understand their reproductive health. She recalled the difficult fertility journey she and her husband experienced and said that tracking fertility data ultimately helped them have three children. The experience showed her how important early access to reproductive health data can be in achieving family-building goals.
White added: “Clue's mission has remained unchanged since its founding. We aim to empower women and people with cycles to take control of their health data, dispel myths, break taboos, and remove barriers.”
How Clue Uses Data to Advance Women's Health Research
Clue's distinctive approach to data collection gives it a leading role in women's health research. With anonymous data voluntarily provided by users, Clue has accumulated more than 15 billion unique data points, creating an important resource for research on menstrual cycles and reproductive health. In 2023, Clue launched Health Record to build the world's largest dataset linking menstrual cycles with diagnoses of women's health conditions, particularly long-overlooked conditions such as PCOS.
Partnerships with institutions including Stanford University and Johns Hopkins University allow Clue to analyze cycle data and identify potential health markers. White noted that PCOS symptoms vary from person to person, and Clue's data may help reveal connections among these symptoms and how they appear across ages and populations.
Clue Supports PCOS Research and Diagnosis
PCOS affects about 10% of women worldwide, yet up to 70% of those affected remain undiagnosed. White noted that many patients spend more than two years and see three doctors before receiving a diagnosis. By collecting data on users' PCOS symptoms, Clue provides researchers with a valuable resource that may clarify the condition's varied presentations and the factors affecting symptom severity.
Clue's partnership with Headspace also supports mental health. By combining Clue's cycle-tracking data with Headspace's mental health resources, Clue can help users manage cycle-related mood changes, stress, and anxiety, especially during major life stages such as trying to conceive, pregnancy, or menopause.
Challenges in Improving PCOS Diagnosis and Treatment
The Clue app helps users track and record symptoms and provides educational content about PCOS so they can identify possible symptoms and discuss them with healthcare providers. Clue has also developed smart reminders that prompt users to seek professional medical advice when cycle abnormalities occur.
White emphasized that Clue aims to use data to advance research, address longstanding information gaps in women's health, and provide personalized health support.
Clue's Future and the Outlook for Women's Health Technology
Clue plans to expand its role as both a consumer app and a research tool while advancing science in menstrual and reproductive health. White said: “We will continue working with leading academic institutions and researchers worldwide to study women's health conditions including PCOS, endometriosis, and PMDD, and to advance early diagnosis and symptom management.”
At the intersection of technology and science, Clue aims to create an accessible, evidence-based women's health platform that provides high-quality data support and helps women make more informed health decisions throughout life.
News | Clue Drives Innovation in Women's Health as CEO Rhiannon White Shares Her Vision
News | Clue Drives Innovation in Women's Health as CEO Rhiannon White Shares Her Vision
Clue's new CEO, Rhiannon White, recently spoke with NewsMedical about her career and Clue's innovative mission in women's health. A leading global menstrual health app, Clue currently serves more than 10 million users across over 190 countries. White explained that Clue uses data to address gaps in women's health research, particularly in under-researched conditions such as polycystic ovary syndrome (PCOS).
Clue's Mission and White's Personal Experience
White joined Clue as Chief Product Officer in 2022 and was recently promoted to CEO. In the interview, she described her strong commitment to Clue's mission and why she joined the company. She was especially drawn to the importance of data in women's health research and its role in helping women understand their reproductive health. She recalled the difficult fertility journey she and her husband experienced and said that tracking fertility data ultimately helped them have three children. The experience showed her how important early access to reproductive health data can be in achieving family-building goals.
White added: “Clue's mission has remained unchanged since its founding. We aim to empower women and people with cycles to take control of their health data, dispel myths, break taboos, and remove barriers.”
How Clue Uses Data to Advance Women's Health Research
Clue's distinctive approach to data collection gives it a leading role in women's health research. With anonymous data voluntarily provided by users, Clue has accumulated more than 15 billion unique data points, creating an important resource for research on menstrual cycles and reproductive health. In 2023, Clue launched Health Record to build the world's largest dataset linking menstrual cycles with diagnoses of women's health conditions, particularly long-overlooked conditions such as PCOS.
Partnerships with institutions including Stanford University and Johns Hopkins University allow Clue to analyze cycle data and identify potential health markers. White noted that PCOS symptoms vary from person to person, and Clue's data may help reveal connections among these symptoms and how they appear across ages and populations.
Clue Supports PCOS Research and Diagnosis
PCOS affects about 10% of women worldwide, yet up to 70% of those affected remain undiagnosed. White noted that many patients spend more than two years and see three doctors before receiving a diagnosis. By collecting data on users' PCOS symptoms, Clue provides researchers with a valuable resource that may clarify the condition's varied presentations and the factors affecting symptom severity.
Clue's partnership with Headspace also supports mental health. By combining Clue's cycle-tracking data with Headspace's mental health resources, Clue can help users manage cycle-related mood changes, stress, and anxiety, especially during major life stages such as trying to conceive, pregnancy, or menopause.
Challenges in Improving PCOS Diagnosis and Treatment
The Clue app helps users track and record symptoms and provides educational content about PCOS so they can identify possible symptoms and discuss them with healthcare providers. Clue has also developed smart reminders that prompt users to seek professional medical advice when cycle abnormalities occur.
White emphasized that Clue aims to use data to advance research, address longstanding information gaps in women's health, and provide personalized health support.
Clue's Future and the Outlook for Women's Health Technology
Clue plans to expand its role as both a consumer app and a research tool while advancing science in menstrual and reproductive health. White said: “We will continue working with leading academic institutions and researchers worldwide to study women's health conditions including PCOS, endometriosis, and PMDD, and to advance early diagnosis and symptom management.”
At the intersection of technology and science, Clue aims to create an accessible, evidence-based women's health platform that provides high-quality data support and helps women make more informed health decisions throughout life.
Source:
Collected online